Noninvasive respiratory support outside the intensive care unit for acute respiratory failure related to coronavirus-19 disease: a systematic review and meta-analysis
Background Noninvasive respiratory support (NIRS) has been diffusely employed outside
the intensive care unit (ICU) to face the high request of ventilatory support due to the …
the intensive care unit (ICU) to face the high request of ventilatory support due to the …
Effectiveness of remdesivir, lopinavir/ritonavir, and favipiravir for COVID-19 treatment: a systematic review
WF Qomara, DN Primanissa, SH Amalia… - … journal of general …, 2021 - Taylor & Francis
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel
strain that causes acute respiratory illnesses known as coronavirus disease 2019 (COVID …
strain that causes acute respiratory illnesses known as coronavirus disease 2019 (COVID …
Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial
Background Awake prone positioning has been reported to improve oxygenation for patients
with COVID-19 in retrospective and observational studies, but whether it improves patient …
with COVID-19 in retrospective and observational studies, but whether it improves patient …
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of …
Abstract Background: COVID-19–related acute illness is associated with an increased risk of
venous thromboembolism (VTE). Objective: These evidence-based guidelines from the …
venous thromboembolism (VTE). Objective: These evidence-based guidelines from the …
[HTML][HTML] European Respiratory Society statement on long COVID follow-up
Patients diagnosed with coronavirus disease 2019 (COVID-19) associated with severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection frequently experience …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection frequently experience …
[HTML][HTML] Respiratory rehabilitation for Covid-19 related persistent dyspnoea: A one-year experience
B Bouteleux, P Henrot, R Ernst, L Grassion… - Respiratory …, 2021 - Elsevier
Background Growing consideration is emerging regarding the burden of persisting sequelae
after SARS-CoV-2 infection. Out-patients exhibiting long Covid may benefit from ambulatory …
after SARS-CoV-2 infection. Out-patients exhibiting long Covid may benefit from ambulatory …
[HTML][HTML] Prospective longitudinal evaluation of hospitalised COVID-19 survivors 3 and 12 months after discharge
N Lorent, YV Weygaerde, E Claeys… - ERJ open …, 2022 - Eur Respiratory Soc
Background Long-term outcome data of coronavirus disease 2019 (COVID-19) survivors are
needed to understand their recovery trajectory and additional care needs. Methods A …
needed to understand their recovery trajectory and additional care needs. Methods A …
Update June 2022: management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline
N Roche, ML Crichton, PC Goeminne… - European respiratory …, 2022 - Eur Respiratory Soc
Since the identification of SARS-CoV-2 at the end of 2019, the coronavirus disease 2019
(COVID-19) pandemic has affected more than 410 million people worldwide and killed …
(COVID-19) pandemic has affected more than 410 million people worldwide and killed …
The use of non-steroidal anti-inflammatory drugs (NSAIDs) in COVID-19
P Kushner, BH McCarberg, L Grange… - NPJ Primary Care …, 2022 - nature.com
Early in the COVID-19 pandemic, anecdotal reports emerged suggesting non-steroidal anti-
inflammatory drugs (NSAIDs) may increase susceptibility to infection and adversely impact …
inflammatory drugs (NSAIDs) may increase susceptibility to infection and adversely impact …
[HTML][HTML] ROX index as predictor of high flow nasal cannula therapy success in acute respiratory failure due to SARS-CoV-2
S Ferrer, J Sancho, I Bocigas, E Bures, H Mora… - Respiratory …, 2021 - Elsevier
Abstract Background High-Flow Nasal Cannula (HFNC) therapy is useful treatment in
patients with acute respiratory failure (ARF). The ROX index (ratio of pulse oximetry/fraction …
patients with acute respiratory failure (ARF). The ROX index (ratio of pulse oximetry/fraction …